Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That was two weeks ago...?
Valid question
I've been accumualting for over a year thanks.
Well, I guess I will hold then...
Ok, well without speculating, all who wish to learn more can reads about what applications the technology holds at the facebook pages.
Thanks for sharing. What did you buy in at if you feel so inclined to tell us about your holdings?
Go to either of the facebook pages, all the info you need
What the????
Unless you have a "margin" account, your shares won't be loaned from what I understand.
It shows they are not trying to deceive shareholders and that open and honest transparency of company actions are in focus. Victories do not come with a few great plays, but consistant and constant play at a top level. Great job GCKO!
Management is keenly aware of whats going on with the stock and is dedicated to beating the short sellers. I am confident that we will prevail.
Sounds like this is a set up for some other news.
Rewards will come with national media coverage and awareness. Don't beat yourselves up over a bad day. There will be more as well as good days. Have a beer and maybe tomorrow will bring good things.
Such are today's markets in general.
ACTC - Agreed, it is ridiculous low right now. I have been accumulating at these levels.
ACTC - "While the injunction has been stayed, it is widely believed that this is only a temporary reprieve, with a permanent injunction a real possibility perhaps as early as the end of this month. Should that come to pass, ACT stands ready to offer its human stem cell lines to the research community, pending their approval by the National Institutes of Health (NIH)."
They are going to rock with an injunction and the approval by the NIH. It's political, with an election coming, the republicans need to focus on the economy, the democrats will rally behind the health care success and win this battle. This is the stem cell play....
ACTC - Advanced Cell Technology Obtains Broad Patent Covering Use of Stem Cell-Derived RPE Cells to Treat Eye Disorders
http://ih.advfn.com/p.php?pid=nmona&article=44359631&symbol=ACTC
I feel you, this has been a touch one. I too help when it went up 600% or so, but i am still convinced this has good times ahead.
With that said, Podoli brings up a good point. Revenue would help grow the pps, GCKO is proving that this day is coming sooner than later. And when that happens, do you want to be on the sideline or in the game? Your call Podoli.
agreed, why would someone want to talk you out of buying a stock? They want it to go down. Who wants it to go down? Shorts. Why do shorts want it to go down? They are scared. Why am i going to stop asking questions that I answer, because it's really annoying.
Funny you say that Kitty, i have been keeping my eye on this for two weeks now and just didn't pull the trigger. Congrats on a good day.
>>>>>>>>>GCKO<<<<<<<<<
GCKO
There are tons of technical analysis boards
Looks like some activity for some reason today.
We some buying here to jump this up
Shorts are trying to cover around the .01-.011 mark.
GCKO - Keep an eye on this going into next week!
I can't imagine we see much selling here today. Nobody in their right mind would see at this point and give the shorts a chance to cover. Next week could be golden.
Grandpa is probably not around...life expectancy and all
GCKO - more news out...triple PR week
http://ih.advfn.com/p.php?pid=nmona&article=44313608&symbol=GCKO
Well the price now around a penny is due to massive shorting of the stock. The actual value of the stock price, based on technology, intellectual property, etc, should be around .09 i have been told by the company. The potential value of the stock based on future events could go much higher. In the short term if we see a short squeeze actually happen, we could see a run up towards the .09 figure. I believe over time, we will see a steady increase eventually up to the .02, then .03, and so on. Higher highs and lower lows from here IMO. With all that said, hey you never know, we are still a goldfish swimming in shark infested waters, but we are starting to grow teeth.
There is a lot of excitement around next week. I am sure not selling anything!
I still have a small position here and check in periodically. Is this ever going to move? The government will spend billions to keep the economy moving, but won't allow research to improve the quality of life. I guess my economics professor was right...misery is good for economic growth.
GCKO - triple PR week.
http://ih.advfn.com/p.php?pid=nmona&article=44313608&symbol=GCKO
GCKO - a company unleashed a tripe pr week. This is a company that is growing and building their product in emerging market of mainstream robotics.
GCKO SIGNS AGREEMENT PARTNERSHIP WITH DELL!!!!!
GeckoSystems and Dell Subsidiary Sign Agreement to Expand Elder Care Robot Trials
GECKOSYSTEMS INTL CO (OTC) (USOTC:GCKO)
Intraday Stock Chart
Today : Tuesday 7 September 2010
GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) announced today that they have successfully negotiated a Memorandum of Understanding (MOU) with a wholly owned contract manufacturing subsidiary of Dell, TriFusion LP. GeckoSystems is a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Serviceā¢."
"We are pleased to announce the signing of this foundation agreement, an MOU in which TriFusion's management commits to sincere efforts in assisting us in meeting our sales goals. While the difficulty in developing cost effective, truly utilitarian mobile robot solutions is 85-90% software R&D, the cost drivers for manufacturing are the mechanical systems, the electronics, and their final assembly into a complete mobile service robot (MSR)," remarked Martin Spencer, President/CEO, GeckoSystems.
TriFusion's approach to bridging the common gap in contract manufacturing services was the fusing of services, technology and logistics to provide an end-to-end solution. Their end-to-end solutions are built on defined and repeatable processes and caped with a web-based tool that provides real-time status of a project 24/7.
GeckoSystems and TriFusion have also executed a five-year, bilateral, binding arbitration non-disclosure agreement (NDA). A similar NDA was executed with Dell some years ago.
"Even though Commercial Off The Shelf (COTS) electronics, electro mechanicals, and mechanical subsystems are used extensively, an experienced, skilled and professionally managed contract manufacturer must be identified, and partnered with in order to hold total direct manufacturing costs to the lowest possible level," said Spencer. "Additionally the contract manufacturer must have the strategic resources that will enable them to scale production up rapidly in the event that the anticipated hyper growth occurs due to pent up demand.
"We are pleased to report that we have found these capabilities and qualities in TriFusion and look forward to our developing relationship as we continue to progress in the expansion of our elder care robot trials. Dell has reassured us on several occasions as to the solidarity of their support of TriFusion. This is very important since it is TriFusion's intimate relationship, and Dell's confirmation of that relationship, that should enable GeckoSystems to benefit from Dell's existing, high volume, low cost computer systems' manufacturing infrastructure to better prepare for our anticipated hyper growth from pent up demand.
"As an illustration of their close, working relationship, at one point recently, Dell requested that they do all billing to GeckoSystems on TriFusion's behalf.
"We have several, very sensitive discussions occurring at this time with other notable potential suppliers and customers, both in the US and Japan. Despite having non-disclosure agreements (NDA's) in place with a number of them, we expect to identify more demonstrable progress -- if not outright successes -- in the near term.
"Since beginning these world's first trials, we have learned that valued family behaviors can be readily expressed to the care receiver using a CareBot due to the robustness of its functionality. There seems to be a very important positive -- and unforeseen by some parties -- impact of valued family behaviors for all members in using a CareBot to communicate their thoughts and feelings to their beloved family members," commented Spencer.
Some believe that the technology is approved and paid for through options such as the Assistive Technology Act of 1998, which broadens the definition, use, and funding of technology at home. Other sources include long-term care insurance, Medicare and Medicaid, Medicaid waivers, and (potentially) stimulus funds from the American Recovery and Reinvestment Act of 2009, under the provisions for health information technology and electronic medical records for acute care.
The elderly frequently endure loneliness and/or loss of independence when living in nursing homes or other assisted living facilities. This new type of remote medical monitoring system, a CareBot, will postpone, if not eliminate that trauma to them. Their families can now better manage the difficult decisions regarding the independence they allow their now dependent parent while enabling the caregiver to hold their risk at a tolerable and acceptable level.
"Since late last year, we have been conducting these world's first elder care robot trials. We have learned a great deal about expected and unexpected human to machine interactions in an elder care setting. Our expectations of anticipated benefits have been, in some instances, much more gratifying than we believed prior to initiating these trials. Consequently our conviction as to there being extraordinary pent up demand for personal assistance robots, like our CareBot, bode well for the ROI that our nearly 1400 investors expect and deserve," concluded Spencer.
good stuff.
No worries, I gave it a 50/50 chance, so a bit of lucky guess for sure :)
GCKO chart please